Pharmacological treatment of the basic defect in cystic fibrosis.

Abstract

Cystic fibrosis (CF) is a genetic disease due to a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel in epithelial cells. There are about 1900 mutations, divided in several groups, for example, stop mutations, mutations affecting the permeability of the channel, and mutations in which the mutated CFTR is… (More)
DOI: 10.1002/cbin.10312

Topics

  • Presentations referencing similar topics